Cite
APA Citation
Dadu, R., Waguespack, S. G., Sherman, S. I., Hu, M. I., Busaidy, N. L., Jimenez, C., Habra, M. A., Ying, A. K., Bassett, R. L., & Cabanillas, M. E. (2014). efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer. Oncologist, 19, 477–482. http://access.bl.uk/ark:/81055/vdc_100054354868.0x00002e